Wedbush restated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com started coverage on Immunic in a research note on Thursday, May 18th. They issued a sell rating on the stock. […]
Wedbush reaffirmed their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday morning, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com initiated coverage on Immunic in a research report on Thursday, May 18th. They set a sell rating on the […]
Immunic (IMUX) Set to Announce Quarterly Earnings on Thursday kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 2,170,000 shares, a growth of 6.9% from the June 15th total of 2,030,000 shares. Based on an average daily volume of 1,040,000 shares, the […]